Detail page

Knowledge Web

Person

Tobias Overbeck (1972-)

Onkologe

Name	Tobias Overbeck
Time	1972- (Date of birth and death)
Place	Göttingen (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Dr. med.
Profession	Onkologe (characteristic profession) Arzt
Variant	Tobias Raphael Overbeck (vollständiger Name) Tobias R. Overbeck T. R. Overbeck T. Overbeck
Related	Universitätsmedizin Göttingen (Geschäftsführender Oberarzt) (Leiter Medizinische und Ambulante Onkologie) (2002-) Lungenkrebs (Thema)
Source	https://haematologie-onkologie.umg.eu/ueber-uns/team (Stand: 19.09.2025) https://www.pathology-congress.de/media/Dgp/Jahrestagung-2024/Overbeck_Tobias_CV_04-2025.pdf (Stand: 19.09.2025)
Record type	Person
GND-Identifier	173585752
Record ID	173585752
Involved in show all Proteasome inhibition as a potential therapeutic target in thymic cancer Treatment of non-small cell lung cancer: advances following the introduction of PET-CT and IMRT/VMAT Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Non-Targeted therapy in Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Thymic Epithelial Tumors Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Targeted Therapies in Non-Small Cell Lung Cancer Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis Predictors of lower exercise capacity in patients with cancer Management of Aortoesophageal Fistula in a Palliative Patient with Non-Small-Cell Lung Cancer: A Case Report Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022 “SpezPat”- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians’ understanding of non-small cell lung cancer patients’ end-of-life decisions Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome : A single-center retrospective analysis of 21 years’ practice SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study Multimodal Treatment of Nasopharyngeal Carcinoma in Children, Adolescents and Young Adults-Extended Follow-Up of the NPC-2003-GPOH Study Cohort and Patients of the Interim Cohort Partielles Ansprechen auf Crizotinib als Erstlinientherapie bei einem älteren männlichen Patienten mit ROS1-Translokations-positivem Bronchialkarzinom Tumorkonferenz I Blastomatoid pulmonary carcinosarcoma: report of a case with a review of the literature Neue Therapie-Ansätze beim Bronchialkarzinom Neue Therapie-Ansätze beim Bronchialkarzinom Detektion pulmonaler Rundherde mit der Spiral-Computertomographie : Vergleich von Maximum-Intensity-Projektionen unterschiedlicher Dicke mit der Einzelschichtbefundung in überlappender Rekonstruktionstechnik

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Tobias Overbeck (1972-)

Proteasome inhibition as a potential therapeutic target in thymic cancer

Treatment of non-small cell lung cancer: advances following the introduction of PET-CT and IMRT/VMAT

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Non-Targeted therapy in Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Thymic Epithelial Tumors

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Targeted Therapies in Non-Small Cell Lung Cancer

Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis

Predictors of lower exercise capacity in patients with cancer

Management of Aortoesophageal Fistula in a Palliative Patient with Non-Small-Cell Lung Cancer: A Case Report

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022

“SpezPat”- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians’ understanding of non-small cell lung cancer patients’ end-of-life decisions

Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome : A single-center retrospective analysis of 21 years’ practice

SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study

Multimodal Treatment of Nasopharyngeal Carcinoma in Children, Adolescents and Young Adults-Extended Follow-Up of the NPC-2003-GPOH Study Cohort and Patients of the Interim Cohort

Partielles Ansprechen auf Crizotinib als Erstlinientherapie bei einem älteren männlichen Patienten mit ROS1-Translokations-positivem Bronchialkarzinom

Tumorkonferenz I

Blastomatoid pulmonary carcinosarcoma: report of a case with a review of the literature

Neue Therapie-Ansätze beim Bronchialkarzinom

Neue Therapie-Ansätze beim Bronchialkarzinom

Detektion pulmonaler Rundherde mit der Spiral-Computertomographie : Vergleich von Maximum-Intensity-Projektionen unterschiedlicher Dicke mit der Einzelschichtbefundung in überlappender Rekonstruktionstechnik